Global Pediatric Catheters Market - 2024-2031

Global Pediatric Catheters Market - 2024-2031

The global pediatric catheters market reached US$ 6.5 billion in 2023 and is expected to reach US$ 11.3 billion by 2031, growing at a CAGR of 7.3% during the forecast period 2024-2031.

Pediatric catheters are urinary catheters that come in sizes suitable for newborns or children. They are designed to address the difficulties related to catheterization in children. Catheters are medical devices prescribed by healthcare professionals.

These catheters are made from high-grade materials used for delivering medications, fluids, and gases to patients or draining bodily fluids such as urine. Pediatric catheters are also known as urinary catheters

The pediatric catheters market is a rapidly growing segment of the medical device industry, driven by factors such as the increasing prevalence of pediatric urological conditions, technological advancements in catheters, and the growing demand for minimally invasive surgical procedures.

Market Dynamics: Drivers

Rising Pediatric Population & Increasing Prevalence of Urinary Tract Infections

The demand for the global pediatric catheter market is driven by multiple factors. One of the key factors driving the market is the rising pediatric population & increasing prevalence of urinary tract infections.

Urinary tract infection (UTI) is one of the most common pediatric infections. According to the Urology Care Foundation in 2024, a UTI is when bacteria gets into your urine and travels up to your bladder. As many as 8 in 100 girls and 2 in 100 boys will get UTIs.

As per MedSpace publication in January 2024, the incidence of UTI in boys exceeds that in girls, first-time & recurrent UTIs are most common in girls. The incidence of UTI in children aged 1-2 years is 8.1% in girls and 1.9% in boys.

Moreover, an increasing number of pediatric patients requiring urological and cardiovascular interventions are expected to grow the demand for the pediatric catheter market.

In addition, key players in the industry strategies such as start-ups and innovations in catheter design would drive this market growth. For instance, in July 2022, a group of experts from across the University of Alabama at Birmingham and Children’s of Alabama, along with local entrepreneurs, launched Zorro-Flow Inc., the newest startup of the UAB Harbert Institute for Innovation and Entrepreneurship.

The product is a neonatal external urine-collection device designed to collect urine safely and effectively in critically ill female neonates and infants under 1 year old.

Restraints

Factors such as product recalls, the high cost of the catheters, the risk of complications associated with catheterization in pediatric patients, lack of awareness, high cost for pediatric doctors, and limited reimbursement policies, are expected to hamper the market.



For more details on this report - Request for Sample

Segment Analysis

The global pediatric catheters market is segmented based on product type, material type, end-user, and region.

The cardiovascular catheters segment accounted for approximately 43.3% of the global pediatric catheters market share

The cardiovascular catheters segment is expected to hold the largest market share over the forecast period. Cardiac catheterization is a nonsurgical, minimally invasive procedure in which a doctor threads thin, flexible tubes called catheters into a blood vessel and guides it to the heart. Cardiac catheterization can help diagnose and treat a variety of congenital and acquired heart conditions in pediatrics.

Moreover, government initiations, technological advancements, and product approvals would drive this segment's growth. For instance, in February 2023, the Ministry of Health announced the opening of the first pediatric cardiac catheterization ward in the governmental health sector in Palestine at the Palestine Medical Complex in Ramallah.

Also, in February 2022, a new larger, and more technologically advanced catheterization laboratory at Children’s of Mississippi is allowing the children’s hospital’s smallest patients to get the cardiac diagnostic care and treatment they need.

Similarly, in, February 2022, Medtronic plc announced that the Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters are the first and only ablation catheters approved by the U.S. Food and Drug Administration (FDA) to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

Geographical Analysis

North America accounted for approximately 42.6% of the global pediatric catheters market share

North America region is expected to hold the largest market share over the forecast period owing to the growing prevalence of congenital heart defects, urological problems, and rising inpatient and emergency room procedures.

Moreover, governments worldwide have implemented several initiatives to extend medical coverage to a large number of previously uninsured individuals. For instance, programs like the Child Health Insurance Program (CHIP) in the U.S. have been established to offer year-long healthcare coverage specifically to children. These initiatives are expected to have a positive impact on the adoption of pediatric catheters over the forecast period.

In addition, advanced healthcare infrastructure, technological innovations, product approvals, and favorable federal initiatives for the development of pediatric catheters are likely to boost the market in North America. For instance, in November 2023, BD launched its new needle-free blood draw technology, PIVO Pro, with FDA clearance. This innovative solution was compatible with integrated catheters, supporting BD's vision of a ""One-Stick Hospital Stay."" It aimed to reduce needlesticks, improve patient experience, and enhance clinical outcomes.

Also, in November 2023, CorMedix Inc. announced FDA approval of DefenCath to reduce the incidence of catheter-related bloodstream infections in adult hemodialysis patients.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global pediatric catheter market. The COVID-19 pandemic has posed tremendous stress on the healthcare system. Its effects on pediatric/congenital catheterization program practice and performance have not been described

According to the Annals of Pediatric Cardiology research publications in October 2021, the reduction in the number of hospitalizations, cardiac surgeries, and catheterization procedures was 66.8%, 73.0%, and 74.3%, respectively.

The reduction in hospitalization was relatively less pronounced among neonates as compared to infants/children and for emergency surgeries as compared to elective indications. The overall in-hospital mortality was higher in 2020 (8.1%) as compared to 2019 (4.8%), with a higher postoperative mortality.

From the same source, 91.2% of the hospitals have canceled elective surgeries. The number of cardiac catheterization procedures for CHD also decreased and all elective cases were canceled among US hospitals.

Congenital cardiac care plummeted across all the age groups, but the comparative outreach for neonatal cardiac care suffered the least, probably because the essential maternal child health and neonatal care services functioned optimally even during the lockdown period in India.

Market Segmentation

By Product Type
• Intravenous Catheters
• Cardiovascular Catheters
• Urology Catheters
• Neurovascular Catheters
• Specialty Catheters

By Material Type
• Polyvinyl Chloride (PVC)
• Silicone
• Polyurethane
• Other Materials

By End User
• Hospitals
• Ambulatory Surgery Centers
• Specialty Clinics

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the pediatric catheter market include Medtronic Inc., BD, Smiths Medical, Edwards Lifesciences Corporation, Cook Medical, Cardinal Health, Coloplast, CIA Medical, Getinge, and 180 Medical, Inc. among others.

Key Developments

 In March 2024, Cook Medical announces a new pediatric indication for the shorter liver access biopsy set. These catheters are used in angiographic procedures, diagnostic procedures, and vascular interventions to make sure medical devices are sized correctly.

 In March 2024, CoapTech, Inc. announces the launch of its Second-Generation Magnetic Balloon Catheter for the PUMA-G System. PUMA-G Pediatrics, where smaller magnets aid in navigating a catheter through a child’s relatively small gastrointestinal tract anatomy.

Why Purchase the Report??
• To visualize the global pediatric catheter market segmentation based on product type, material type, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of global pediatric catheter market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.

The global pediatric catheters market report would provide approximately 62 tables, 55 figures, and 181 Pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies